Tissue plasminogen activator reduces intraperitoneal adhesion after intestinal resection in rats

Journal of the Formosan Medical Association

Volumn 97, Issue 5, 1998, Pages 323-327

  Lai, Hong Shiee ^a   Chen, Yun ^a   Chang, King Jen ^a   Chen, Wei Jao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Intestinal resection; Intraperitoneal adhesion; Plasminogen activator inhibitor; Tissue plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; FIBRINOLYSIS; INTESTINE RESECTION; LAVAGE; MALE; NONHUMAN; PERITONEUM CELL; PLASMINOGEN ACTIVATION; RAT; WOUND HEALING;

ADHESIONS; ANIMALS; INTESTINES; MALE; PERITONEAL DISEASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031744880     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Scott-Coombes DM, Vipond MN, Thompson JN: General surgeons' attitudes to the treatment and prevention of abdominal adhesions. Ann R Coll Surg Engl 1993;75:123-8.
2. Menzies D, Ellis H: Intestinal obstruction from adhesions-how big is the problem? Ann R Coll Surg Engl 1990;72:60-3.
3. Ellis H: The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg 1997;577(Suppl):5-9.
4. Scott-Coombes D, Whawell SA, Vipond MN, et al: Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 1995;82:414-7.
5. Milligan DW, Raftery AT: Observations on the pathogenesis of peritoneal adhesions: a light and electron microscopical study. Br J Surg 1974;61:274-80
6. Vipond MN, Whawell SA, Thompson JN, et al: Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990;335:1120-2.
7. Held C, Hjemdahl P, Rehnqvist N, et al: Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm. Circulation 1997;95:2380-6.
8. Grau GE, de Moerloose P, Bulla O, et al: Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells. Thromb Haemost 1997;77:585-90.
9. Rijken DC, Collen D: Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981;256: 7035-41.
10. Thompson JN, Paterson-Brown S, Harbourne T, et al: Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989;76:382-4.
11. Ieko M, Sawada K, Yasukouchi T, et al: Protection by α2-macroglobulin of tissue plasminogen activator against inhibition by plasminogen activator inhibitor-1. Br J Haematol 1997;97:214-8.
12. Dunn RC, Buttram VC: Tissue-type plasminogen activator as an adjuvant for post surgical adhesions. Prog Clin Biol Res 1990;358:113-8.
13. Menzies D, Ellis H: The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet 1991;172:362-6.
14. Lai HS, Chen Y: Effect of octreotide on postoperative intraperitoneal adhesions in rats. Scand J Gastroenterol 1996;31:678-81.
15. Yaacobi Y, Goldberg EP, Habal MB: Effect of Ringer's lactate irrigation on the formation of postoperative abdominal adhesions. J Invest Surg 1991;4:31-6.
16. Bothin C, Midtvedt T: The role of the gastrointestinal microflora in postsurgical adhesion formation - a study in germ free rats. Eur Surg Res 1992;24:309-12.
17. Williams RS, Rossi AM, Chegini N, et al: Effect of transforming growth factor β on postoperative adhesion formation and intact peritoneum. J Surg Res 1992;52: 65-75.
18. Urman B, Gomel V, Jetha N: Effect of hyaluronic acid on postoperative intraperitoneal adhesion formation in the rat model. Fertil Steril 1991;56:568-70.
19. Haney AF, Doty E. Murine peritoneal injury and de novo adhesion formation caused by oxidized-regenerated cellulose (Interceed [TC7]) but not expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane). Fertil Steril 1992;57:202-8.
20. Rivkind AI, Lieberman N, Durst AL: Urokinase does not prevent abdominal adhesion formation in rats. Eur Surg Res 1985;17:254-8.
21. Al-Chalabi HA, Otubo JAM: Value of a single intraperitoneal dose of heparin in prevention of adhesion formation: an experimental evaluation in rats. Int J Fertil 1987;32:332-5.
22. Wang L, Kittaka M, Sun N, et al: Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J Cereb Blood Flow Metabol 1997;17:136-46.
23. Killewich LA, Macko RF, Gardner AW, et al: Defective fibrinolysis occurs after infrainguinal reconstruction. J Vasc Surg 1997;25:858-64.
24. Ränby M, Brändström A: Biological control of tissue plasminogen activator-mediated fibrinolysis. Enzyme 1988;40:130-43.
25. Vipond MN, Whawell SA, Scott-Coombes DM, et al: Experimental adhesion prophylaxis with recombinant tissue plasminogen activator. Ann R Coll Surg Engl 1994; 76:412-5.
26. Orita H, Fukasawa M, Girgis W, et al: Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator. Int J Fertil 1991;36:172-7.